Speakers at the European Society of Cardio-Thoracic Surgery annual meeting (EACTS 2021; 13–16 October; Barcelona, Spain and virtual) addressed the thorny topic of left main revascularisation, with discussion focusing on the controversy surrounding the EXCEL trial and the reflection of the data in current clinical guidelines.
Speakers at the European Society of Cardio-Thoracic Surgery annual meeting (EACTS 2021; 13–16 October; Barcelona, Spain and virtual) addressed the thorny topic of left main revascularisation, with discussion focusing on the controversy surrounding the EXCEL trial and the reflection of the data in current clinical guidelines.
The longest available real-world follow-up data of transcatheter mitral valve implantation (TMVI) using the first-generation Tendyne (Abbott) has shown symptomatic improvements in patients, with low periprocedural complication rates. These were the findings presented at the European Society of Cardio-Thoracic Surgery annual meeting (EACTS 2021; 13–16 October; Barcelona, Spain and virtual) by Alicja Zientara (Royal Brompton Hospital, London, UK) who detailed single-centre experience and a review of echocardiographic parameters following implantation of the Tendyne device.
Cardiac CT angiography (CTA) derived left atrium emptying fraction (LAEF) improves predictive performance of established clinical risk scores and may be used to assess patients’ risk during pre-transcatheter aortic valve implantation (TAV) work-up and post-procedural surveillance.
HeartFlow has announced the commencement of the REVEALPLAQUE trial to evaluate the company’s non-invasive plaque technology, an automated, deep learning-based method for identifying, characterising and segmenting plaque in the coronary arteries. The first two patients were enrolled at Bryan Heart in Lincoln, USA by interventional cardiologists Brock Cookman and Clyde R Meckel.
The expansion of transcatheter aortic valve implantation (TAVI) in the USA has predominantly centred on wealthier, metropolitan areas, with hospitals in poorer, more rural communities less likely to offer the procedure.
The expansion of transcatheter aortic valve implantation (TAVI) in the USA has predominantly centred on wealthier, metropolitan areas, with hospitals in poorer, more rural communities less likely to offer the procedure.
The expansion of transcatheter aortic valve implantation (TAVI) in the USA has predominantly centred on wealthier, metropolitan areas, with hospitals in poorer, more rural communities less likely to offer the procedure.
The underrepresentation of women in clinical coronary revascularisation trials may encourage treatment that favours outcomes in men, despite the presence of significant differences in the clinical characteristics between women and men. This is according to speakers at the European Society of Cardio-Thoracic Surgery annual meeting (EACTS 2021; 13–16 October; Barcelona, Spain and virtual) in a panel session which considered current data concerning women undergoing coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI).
OpSens has announced the commencement of the human clinical study utilising the SavvyWire, and successful treatment of the first patients. The SavvyWire, developed initially for transcatheter aortic valve implantation (TAVI), is intended to both deliver a valvular prosthesis while allowing continuous haemodynamic pressure measurement during the procedure.
ReCor Medical has announced that its Paradise ultrasound renal denervation system is now available for the treatment of uncontrolled hypertension in Germany. The first hospitals performing the procedure commercially are Heart Center Leipzig, Leipzig and Saarland University Hospital, Homburg/Saar.
OpSens has announced the commencement of the human clinical study utilising the SavvyWire, and successful treatment of the first patients. The SavvyWire, developed initially for transcatheter aortic valve implantation (TAVI), is intended to both deliver a valvular prosthesis while allowing continuous haemodynamic pressure measurement during the procedure.
Performance diagnostique de l’interféron gamma dans l’identification de l’origine tuberculeuse des pleurésies exsudatives
A Mixed Phenotype of Airway Wall Thickening and Emphysema Is Associated with Dyspnea and Hospitalization for Chronic Obstructive Pulmonary Disease.
Radiological Approach to Asthma and COPD-The Role of Computed Tomography.
Significant annual cost savings found with UrgoStart in UK and Germany
Thrombolex announces 510(k) clearance of Bashir catheter systems for thromboembolic disorders
Phone: (028) 3981 2678
Mobile: 0903 839 878 - 0909 384 389